ArticleCell death & disease2016

Non-amyloidogenic effects of α2 adrenergic agonists: implications for brimonidine-mediated neuroprotection.

Shereen Nizari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.